Monday Nov 25
Ranbaxy Laboratories May Sell Off Exit Vaccine Business
Drug maker Ranbaxy Laboratories is likely to sell off Biovel, a Bangalore-based vaccine manufacturing company which it had acquired in 2010, sources said.
Wockhardt eyes listing in Europe
It's rare for Indian drug companies to list overseas. Ranbaxy Laboratories and Dr Reddy's Laboratories are the only two Indian drug makers to have done so.
Singh Brothers Of Ranbaxy Laboratories Concealed Facts While Selling Stake: Daiichi Sankyo, Inc.
Japanese pharmaceutical company Daiichi Sankyo has accused Malvinder Mohan Singh and Shivinder Mohan Singh of concealing and misrepresenting facts at the time of its $2.4-billion purchase of a controlling stake in Ranbaxy Laboratories in 2008 from the brothers.
Ranbaxy whistle-blower says drug maker faked data
A general view of the office of Ranbaxy Laboratories is pictured at Gurgaon, on the outskirts of New Delhi Washington: An Indian origin whistle-blower, who exposed a massive fraud by the Indian pharmaceutical giant Ranbaxy, has accused the generic drug maker of faking test results for approval by the US drug regulator.Generic drug companies such as ... (more)
Ranbaxy Laboratories 3QCY2013 performance highlights and results update
Ranbaxy Laboratories posted lower-than-expected numbers on the OPM and the net profit front.